KCI USA, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $15.2M | 34 | 32.3% |
| Unspecified | $8.5M | 507 | 18.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8.2M | 2,064 | 17.3% |
| Consulting Fee | $5.5M | 3,574 | 11.7% |
| Travel and Lodging | $3.0M | 7,686 | 6.3% |
| Debt forgiveness | $2.3M | 109 | 4.9% |
| Food and Beverage | $1.8M | 42,976 | 3.9% |
| Grant | $1.5M | 151 | 3.3% |
| Education | $607,911 | 598 | 1.3% |
| Long term medical supply or device loan | $110,354 | 100 | 0.2% |
| Space rental or facility fees (teaching hospital only) | $98,182 | 3 | 0.2% |
| Compensation for serving as faculty or as a speaker for a medical education program | $91,903 | 14 | 0.2% |
| Honoraria | $68,686 | 33 | 0.1% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $14,750 | 5 | 0.0% |
| Gift | $1,322 | 13 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| Closed Incision Negative Pressure Therapy Versus Standard of Care Surgical Dressing in Revision Total Knee Arthroplasty | $956,006 | 0 | 111 |
| The Management of Closed Surgical Incisions Resulting from Incisional Hernia Repair and or Functional Panniculectomy Using the Prevena Customizable Dressing | $492,625 | 0 | 17 |
| Mild Perioperative Hypothermia and Major Adverse Cardiovascular Outcomes/Troponin - Cleveland Clinic | $441,309 | 0 | 1 |
| Povidone-iodine to Stop Access-related Infections and Transmission of Staphylococcus aureus (PAINTS) | $436,475 | 0 | 1 |
| A Prospective, Single-arm, Multi-center, Open Label Trial Evaluating the Continuous Application of Prevena Therapy for up to 14 days | $311,749 | 0 | 15 |
| KCI.PREVENA.2017.01 Post-market, Randomized, Open-Label, Multicenter, Study to Evaluate the Effectiveness of Closed Incision Negative Pressure Therapy versus Standard of Care Dressings in Reducing Surgical Site Complications in Subjects with Revision of a Failed Total Knee Arthroplasty PROMISES | $248,390 | 0 | 27 |
| Multicenter randomized controlled trial of a negative pressure incision management system in high risk vascular surgery patients | $203,109 | 0 | 11 |
| UTAH Breast recon registry - Agarwal - Griffin | $193,066 | 0 | 2 |
| Closed Incision Negative Pressure Therapy Versus Standard of Care Surgical Dressing in Revision Total Knee Arthroplasty PROMISES | $174,987 | 0 | 8 |
| Intellicure - Post-market clinical follow-up data collection | $160,000 | 1 | 1 |
| Wound Registry for Patients Undergoing Surgical Wound Debridements of the Upper or Lower Extremities | $159,696 | 0 | 3 |
| Evaluation of Negative Pressure Wound Therapy for Reduction of Postoperative Surgical Site infection in Human Patients Undergoing Colorectal and Hepatopancreatobiliary Surgery | $159,029 | 0 | 4 |
| Evaluation of Negative Pressure Wound Therapy for Reduction of Postoperative Surgical Site Infection in Patients Undergoing Colorectal and Hepatopancreatobiliary Surgery | $150,341 | 0 | 4 |
| A prospective, single-center study evaluating the impact of the 3M Prevena Restor BellaForm Incision Management System on blood and lymphatic flow following reduction mammaplasty | $149,250 | 0 | 1 |
| Intellicure - Study - RW Coban 2 layer & NPWT in VLU's | $146,000 | 1 | 2 |
| Hydromechanical Cleansing with VAC VERAFLO CLEANSE CHOICE Dressing and NPWTi-d vs. Collagenase Ointment in the Management of Pressure Ulcer Injuries (ACCELERATE Trial) | $144,556 | 0 | 28 |
| Exploratory prospective two-arm cohort study to evaluate functional outcomes in patients with high-risk lower extremity fractures requiring open reduction and internal fixation | $136,990 | 0 | 1 |
| KelaHealth - Vascular Surgery Collaborative Research Agreement June 2021 | $124,650 | 0 | 1 |
| Negative Pressure Wound Therapy for prevention of surgical site infections in high risk patients with diabetes and morbid obesity | $122,000 | 0 | 3 |
| Intellicure - Post-market clinical follow-up data collection - 2nd Year Installment | $120,000 | 1 | 1 |
| Evaluation of Vacuum-Assisted Closure VERAFLO Therapy with Cleanse Choice Dressing on Wound Healing | $116,644 | 0 | 1 |
| 3M Tissue Adhesive vs. Commercially Available Tissue Adhesive for Closure of Traumatic Lacerations and Surgical Incision | $106,911 | 0 | 1 |
| Retrospective and Prospective Analyses of Real World Evidence to Compare Use of KCI and 3M Products vs. Alternative Treatment Protocols on Various Wounds | $105,902 | 0 | 7 |
| Prevena Study at Northwestern University / Dr. Robert Galiano Year 1 | $102,167 | 0 | 1 |
| Evaluation of Vacuum-Assisted Closure Veraflo Therapy with Cleanse Choice Dressing on Wound Healing in Patients with Pressure Sores: A Prospective, Randomized Controlled Trial | $102,038 | 0 | 1 |
| Orthopaedic Trauma Registry for Patients undergoing urgical procedures at high rick for wound complications. | $101,501 | 0 | 2 |
| Negative Pressure Wound Therapy in post-operative incision management | $100,250 | 0 | 5 |
| University of Utah - Dr Agarwal - Collaborative Clinical Research related to the Breast Reconstruction Registry | $96,533 | 0 | 1 |
| Establishment of a Multi-Center Breast Reconstruction Registry | $84,678 | 0 | 1 |
| KERALITCPMCF008: A Prospective, Observational, Post Market Clinical Follow-up (PMCF) Study in Patient using the KerraLite Cool Dressing on Radiation Therapy Damage Wounds, Burns and Dry Wounds | $78,565 | 0 | 9 |
Payments by Medical Specialty
Top Paid Doctors — Page 3
| Doctor | Specialty | Location | Total | 2023 |
|---|---|---|---|---|
| Dr. Brent Bernstein, D.p.m, D.P.M | Foot & Ankle Surgery | Fort Myers, FL | $84,327 | $0 |
| Elizabeth Benjamin, Md, MD | Surgery | Atlanta, GA | $83,070 | $0 |
| Kersten Reider, Crnp, CRNP | Primary Care | Mount Penn, PA | $74,729 | $0 |
| Dr. Rafael Gottenger, Md, MD | Plastic Surgery | South Miami, FL | $73,394 | $0 |
| Risal Djohan, Md, MD | Plastic Surgery | Cleveland, OH | $72,646 | $0 |
| Dr. Aaron Strumwasser, Md, MD | Surgical Critical Care | Lynwood, CA | $70,184 | $0 |
| Dr. Owen Johnson, Md, MD | Plastic Surgery | Tacoma, WA | $68,611 | $0 |
| Jeffrey Litt, Do, DO | Surgery | Richmond, VA | $67,166 | $0 |
| Alisha Oropallo, M.d, M.D | Vascular Surgery | Mineola, NY | $64,529 | $0 |
| Dr. Carlos Higuera Rueda, M.d, M.D | Adult Reconstructive Orthopaedic Surgery | Weston, FL | $63,000 | $0 |
| Robert Meneghini, Md, MD | Orthopaedic Surgery | Indianapolis, IN | $59,352 | $0 |
| Dr. Scot Glasberg, M.d, M.D | Plastic Surgery | New York, NY | $58,081 | $0 |
| Dr. Christopher Pelt, M.d, M.D | Orthopaedic Surgery | Salt Lake City, UT | $57,002 | $0 |
| Dr. Robert Grant, M.d, M.D | Plastic and Reconstructive Surgery | New York, NY | $56,887 | $0 |
| Dr. Evan Argintar, Md, MD | Sports Medicine | Washington, DC | $55,313 | $0 |
| Dr. William Tettelbach, Md, MD | Infectious Disease | Salt Lake City, UT | $54,938 | $0 |
| Dr. Boris Zelle, Md, MD | Orthopaedic Surgery | San Antonio, TX | $53,736 | $0 |
| Mark Albert, M.d, M.D | Plastic Surgery | New York, NY | $52,338 | $0 |
| Dr. Levester Kirksey, Md, MD | Vascular Surgery | Cleveland, OH | $52,152 | $0 |
| Dr. Lucian Vlad, M.d, M.D | Family Medicine | Winston Salem, NC | $51,513 | $0 |
| John Lantis, Md, MD | Vascular Surgery | New York, NY | $50,251 | $0 |
| Dr. Vikisha Fripp, M.d, M.D | Family Medicine | Washington, DC | $49,097 | $0 |
| Dr. Alberto Aviles, M.d, M.D | Plastic Surgery | Southfield, MI | $46,194 | $0 |
| Andrew Applewhite, Md, MD | Family Medicine | Dallas, TX | $45,238 | $0 |
| Dr. David Rivadeneira, M.d, M.D | Colon & Rectal Surgery | Woodbury, NY | $44,519 | $0 |
Top Products
- PREVENA $21.7M
- VAC VERAFLO $3.2M
Associated Products (52)
- PREVENA $22.9M
- VAC VERAFLO $3.2M
- SNAP $1.5M
- ABTHERA $1.4M
- ACTIV.A.C. $1.2M
- 3M Cavilon $911,874
- Prevena $875,369
- CELLUTOME $811,652
- ACTIVAC $656,091
- V.A.C. VERAFLO $596,554
- V.A.C. DERMATAC $592,068
- ADAPTIC $580,303
- Bair Hugger $458,948
- VAC VERAFLO CLEANSE CHOICE $448,570
- BAIR HUGGER TEMPERATURE MONITORING SYSTEM (SPOTON) $446,441
- V.A.C. VERAFLO CLEANSE CHOICE $431,058
- Cavilon Advanced Skin Protectant $300,089
- 3M Coban $257,595
- DERMATAC $257,051
- PREVENA RESTOR BELLAFORM $248,388
- ABTHERA ADVANCE $219,419
- VAC ULTA $212,663
- Coban $174,235
- VAC INSTILL $161,503
- Curos $149,014
- Tegaderm $115,636
- KerraLite Cool $104,927
- BIOSORB $104,556
- ATTEST $104,542
- VAC ATS $78,289
- PROMOGRAN PRISMA $70,013
- SILVERCEL $67,767
- Bair Paws $62,632
- Cavilon $55,941
- SpotOn $48,275
- 3M Micropore $42,946
- V.A.C. ULTA $41,312
- KerraCel Ag $37,322
- PREVENA RESTOR ROTO-FORM $34,826
- PREVENA RESTOR BELLA-FORM $33,766
- KERRAFOAM GENTLE BORDER $33,467
- V.A.C.INSTILL $26,733
- FISTULA SOLUTION $25,318
- VAC RX4 $25,092
- KERRACEL AG $22,528
- BIOCLUSIVE $16,483
- Steri-Vac $14,884
- ACTIV.A.C. iOn PROGRESS $13,050
- TIELLE $11,485
- KERRACEL $11,231
- KerraLite $10,146
- KERRACONTACT AG (US) $10,017
Payment Categories
- Food & Beverage $1.8M
- Consulting $5.5M
- Travel & Lodging $3.0M
- Research $8.5M
- Royalties $15.2M
About KCI USA, Inc.
KCI USA, Inc. has made $47.1M in payments to 25,378 healthcare providers, recorded across 57,867 transactions in the CMS Open Payments database. In 2023, the company paid $7.6M. The top product by payment volume is PREVENA ($21.7M).
Payments were distributed across 217 medical specialties. The top specialty by payment amount is Plastic Surgery ($17.9M to 882 doctors).
Payment categories include: Food & Beverage ($1.8M), Consulting ($5.5M), Research ($8.5M), Travel & Lodging ($3.0M), Royalties ($15.2M).
KCI USA, Inc. is associated with 52 products in the CMS Open Payments database, including PREVENA, VAC VERAFLO, and SNAP.